toyocamycin has been researched along with ribavirin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balzarini, J; De Clercq, E; Hansske, F; Madej, D; Robins, MJ | 1 |
Balzarini, J; Bergstrom, DE; Brattesani, AJ; De Clercq, E; Ogawa, MK; Reddy, PA; Schweickert, MJ | 1 |
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
3 other study(ies) available for toyocamycin and ribavirin
Article | Year |
---|---|
Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; Formycins; Leukemia L1210; Mice; Microbial Sensitivity Tests; Pyrimidine Nucleosides; Ribonucleosides; Structure-Activity Relationship; Toyocamycin; Tubercidin | 1987 |
Antiviral activity of C-5 substituted tubercidin analogues.
Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; Chlorocebus aethiops; DNA Viruses; HeLa Cells; Humans; Mice; Pyrimidine Nucleosides; Rabbits; Ribonucleosides; RNA Viruses; Toyocamycin; Tubercidin | 1984 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |